Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04037605 · ClinicalTrials.gov registry record · Early Phase 1
Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women
A Early Phase 1 study of Sleep Restriction, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
- Active
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT04037605 is a Early Phase 1 study of Sleep Restriction that is active but no longer recruiting, run by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. The registered enrollment target is 5 participants, below the 66-participant average among 4 other Sleep Restriction trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04037605, a Early Phase 1 study of Sleep Restriction, is active but no longer recruiting, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to 1) determine how hypothalamic-pituitary-adrenal axis (HPA axis) activation occurs with sleep restriction and 2) evaluate how hypothalamic-pituitary-gonadal axis (HPG axis) deactivation occurs with sleep restriction. The investigator will also examine the cognitive function associated with sleep restriction, including food intake and food cravings.
Conditions Studied
Interventions
- DRUG Ganirelix
- DRUG Cosyntropin Injectable Product
- DRUG Ketoconazole Pill (also known as nizoral)
- DRUG Dexamethasone Pill
- DRUG Dexamethasone injection
Study Locations (1)
California
- Los Angeles Biomedical Research Institute - Torrance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2020-02-09 |
| Est. Completion | 2026-06-24 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04037605
The ClinicalTrials.gov registry entry for NCT04037605 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 66-participant average among 4 other Sleep Restriction trials with a reported enrollment target (92% lower). The listed sponsor is Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sleep Restriction appearing as the primary indexed condition, and to 5 interventions - of which Ganirelix is the first listed.
NCT04037605 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04037605 about?
NCT04037605 is a clinical study titled "Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women". The purpose of this study is to 1) determine how hypothalamic-pituitary-adrenal axis (HPA axis) activation occurs with sleep restriction and 2) evaluate how hypothalamic-pituitary-gonadal axis (HPG axis) deactivation occurs with sleep restriction. The investigator will also examine the cognitive fun...
What is the current status of trial NCT04037605?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2020-02-09. Estimated completion is 2026-06-24.
What conditions does trial NCT04037605 study?
This clinical trial studies the following conditions: Sleep Restriction.
What interventions are being tested in trial NCT04037605?
The interventions under investigation include: Ganirelix (DRUG), Cosyntropin Injectable Product (DRUG), Ketoconazole Pill (also known as nizoral) (DRUG), Dexamethasone Pill (DRUG), Dexamethasone injection (DRUG).
Who is sponsoring clinical trial NCT04037605?
This trial is sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04037605 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Restriction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sleep and Inflammatory Resolution Pathway
ACTIVE NOT RECRUITING · Early Phase 1
-
Acoustic Stimulation During Restricted Sleep After Sleep Deprivation
RECRUITING · NA
-
Hormonal Mechanisms of Sleep Restriction - Axis Study
ACTIVE NOT RECRUITING · Phase 1
-
Impact of a Sleep Debt in Middle-Aged and Older Adults
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.